Whacky Wednesday!
The Market Ticker ® - Commentary on The Capital Markets
Posted 2007-05-09 08:41
by Karl Denninger
 
Top of the morning!

First on the list, Dendreon (DNDN) blew up this morning; the FDA issued an "Approvable" letter, essentially demanding more information on the company's drug Provenge. The stock was instantly cut by more than 50%, now trading around $8 in premarket. Those who bought into the meteroric rise of this issue after the advisory panel are going to be hurt severely this morning, while shorts are cheering - they live to fight another day.

Futures are down moderately; everyone is pretty much waiting for the Fed, with the FOMC meeting starting today. Nobody really expects a change in the Fed's stance - it would be a true shocker if there was any net-net change in posture, although the statement may give clues to what they think is coming next. I personally expect them to remain hawkish on inflation.

Countrywide (CFC) is fading back premarket after their stupidity-driven run on takeover "chatter" - as pointed out last night, this is a non-starter.

I will be watching the indices and my indicators closely today for clues. The wedge, as noted before, is basically out of room - and the break one way or the other is likely to come any day now - in fact, it could easily come today.

Updated if and when warranted!
Discuss this entry (registration required to post)
 

Main Navigation
Full-Text Search & Archives
Archive Access
Get Adobe Flash player





Blogtalk 3:30 CT Mondays
Items To Look At


Discuss The Capital Markets along with daily technical analysis with our Gold Donor program.

Where We Are, Where We're Heading (2012) - The annual 2012 Ticker

Links and Blogroll
Our policy on reciprocal links: Send us an email with your information and why you think your blog or news site would make a good addition - in most cases reciprocal link requests will be granted.
Seeking Alpha Certified
Legal Disclaimer

The content on this site is provided without any warranty, express or implied. All opinions expressed on this site are those of the author and may contain errors or omissions.

NO MATERIAL HERE CONSTITUTES "INVESTMENT ADVICE" NOR IS IT A RECOMMENDATION TO BUY OR SELL ANY FINANCIAL INSTRUMENT, INCLUDING BUT NOT LIMITED TO STOCKS, OPTIONS, BONDS OR FUTURES.

The author may have a position in any company or security mentioned herein. Actions you undertake as a consequence of any analysis, opinion or advertisement on this site are your sole responsibility.

Looking for "The Best of Market Ticker"? Check out
Ticker Classics.

Visit the forum to discuss this and other investing-related topics; see the FAQ on the forum for information about Gold Donor status including access to our technical analysis video server.

Market charts, when present, used with permission of TD Ameritrade/ThinkOrSwim Inc. Neither TD Ameritrade or ThinkOrSwim have reviewed, approved or disapproved any content herein.

Market Ticker content may be reproduced or excerpted online provided full attribution is given and the original article source is linked to. Please contact Karl Denninger for reprint permission in other media.